Journal
AMINO ACIDS
Volume 32, Issue 2, Pages 203-212Publisher
SPRINGER
DOI: 10.1007/s00726-006-0370-6
Keywords
amino acids; dipeptides; liquid chromatography; tandem mass spectrometry; cerebrospinal fluid; plasma; urine
Categories
Funding
- NINDS NIH HHS [R01 NS43295] Funding Source: Medline
Ask authors/readers for more resources
Our aim was to develop a liquid chromatography and electrospray ionization tandem mass spectrometry (LCMS2) method to measure free amino acid (FAA) and dipeptide (DP) concentrations in biological fluids. We synthesized chloroformate derivatives of FAA and DP, identified the major precursor ions and used LCMS2 to obtain the most intense product ions. Using serial dilutions of unlabeled and labeled standards ([H-2(3)]-L-Dopa, homoarginine, homophenylalanine, [N-15]-Glutamine and [H-2(3)]-methionine), we observed linear relationships in MS response that we used to calculate the amounts of FAA and DP in biological samples. This method is sensitive with a limit of detection (LOD) for most of the FAAs and DPs tested in the 0.05-1 pmol range and is linear over 3-5 orders of magnitude when many metabolites were measured simultaneously. Reproducibility and between run or daily variations were < 10% for most FAAs and DPs. We applied this method to human samples and quantitatively measured 21 FAAs and 2 DPs in 200 mu l CSF, 31 FAAs and 6 DPs in 100 mu l plasma, and 23 FAAs and 5 DPs in 200 mu l urine. These data demonstrate the potential for using LCMS2 to discover changes in FAA and DP metabolic pathways that occur during disease pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available